# Dose-Ranging Safety and Efficacy Study of Topical Creams Containing API 31510 for the Treatment of in Situ Cutaneous Squamous Cell Carcinoma

> **NCT00605709** · PHASE2 · WITHDRAWN · sponsor: **BPGbio**

## Conditions studied

- Squamous Cell Carcinoma

## Interventions

- **DRUG:** API 31510 Topical Cream

## Key facts

- **NCT ID:** NCT00605709
- **Lead sponsor:** BPGbio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-03
- **Primary completion:** 2008-07
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2012-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00605709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00605709, "Dose-Ranging Safety and Efficacy Study of Topical Creams Containing API 31510 for the Treatment of in Situ Cutaneous Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00605709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*